Tens of thousands of high-risk Israelis can now get an antibody treatment as hospital outpatients as soon as they are diagnosed with COVID-19, in the hope that it will prevent deterioration to serious illness.
The Health Ministry has a supply of thousands of doses of the US-made Bamlanivimab, which is intended specifically for non-serious patients. It has started distributing them to doctors, who are now offering the two-hour infusion-based treatment to outpatients in certain high-risk categories who test positive for the virus.
Jerusalem’s Hadassah Medical Center became the first institution to start giving the treatment on Monday, administering it to four outpatients, and other hospitals are expected to follow.
Bamlanivimab is composed of monoclonal antibodies, which are laboratory-made proteins that mimic the immune system’s ability to fight off harmful antigens including viruses.
Read more at Times of Israel.
{Matzav.com}
It seems that Moshiach is right around the corner and Bibi and the Health Minister got the prophecy to make sure that the amount of people who perished before Yetzias Mitzrayim (80%) will perish before Moshiach comes.
“וְלֹא תִקַּח שֹׁחַד כִּי הַשֹּׁחַד יְעַוֵּר עֵינֵי חֲכָמִים וִיסַלֵּף דִּבְרֵי צַדִּיקִם”
(דברים ט”ז י”ט)
How is this different from the antibody treatment the community was behind at the beginning of the pandemic, that didn’t work as anticipated?
I’m confused. I received monoclonal in USA and was told it must be administered only days 3-5 of virus. Can anyone elaborate?